245 related articles for article (PubMed ID: 21362574)
1. Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years.
Glueck CJ; Morrison JA; Daniels S; Wang P; Stroop D
J Pediatr; 2011 Aug; 159(2):308-13.e2. PubMed ID: 21362574
[TBL] [Abstract][Full Text] [Related]
2. Adolescent oligomenorrhea (age 14-19) tracks into the third decade of life (age 20-28) and predicts increased cardiovascular risk factors and metabolic syndrome.
Glueck CJ; Woo JG; Khoury PR; Morrison JA; Daniels SR; Wang P
Metabolism; 2015 Apr; 64(4):539-53. PubMed ID: 25633270
[TBL] [Abstract][Full Text] [Related]
3. Adolescent oligomenorrhea in a biracial schoolgirl cohort: a simple clinical parameter predicting impaired fasting glucose plus type 2 diabetes mellitus, insulin, glucose, insulin resistance, and centripetal obesity from age 19 to 25 years.
Morrison JA; Glueck CJ; Daniels S; Wang P; Stroop D
Metabolism; 2011 Sep; 60(9):1285-93. PubMed ID: 21419463
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sex hormone-binding globulin on predicting metabolic syndrome in newly diagnosed and untreated patients with polycystic ovary syndrome.
Fu C; Minjie C; Weichun Z; Huihuang Y; Guishan C; Qingxia H; Xiaoping Y; Lan C; Ping W; Chujia L; Guoshu Y
Hormones (Athens); 2020 Sep; 19(3):439-445. PubMed ID: 32562143
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea.
Kim MJ; Lim NK; Choi YM; Kim JJ; Hwang KR; Chae SJ; Park CW; Choi DS; Kang BM; Lee BS; Kim T; Park HY
PLoS One; 2014; 9(6):e99252. PubMed ID: 24901345
[TBL] [Abstract][Full Text] [Related]
6. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
Ezeh U; Ezeh C; Pisarska MD; Azziz R
Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
[TBL] [Abstract][Full Text] [Related]
7. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
[TBL] [Abstract][Full Text] [Related]
8. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome.
Nezi M; Christopoulos P; Paltoglou G; Gryparis A; Bakoulas V; Deligeoroglou E; Creatsas G; Mastorakos G
J Pediatr Endocrinol Metab; 2016 Jun; 29(6):693-702. PubMed ID: 27089404
[TBL] [Abstract][Full Text] [Related]
9. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
[TBL] [Abstract][Full Text] [Related]
10. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome.
Penttilä TL; Koskinen P; Penttilä TA; Anttila L; Irjala K
Fertil Steril; 1999 Mar; 71(3):457-61. PubMed ID: 10065782
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
12. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
13. Obesity and inflammatory biomarkers in women with polycystic ovary syndrome.
Shen SH; Shen SY; Liou TH; Hsu MI; Chang YC; Cheng CY; Hsu CS; Tzeng CR
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():66-71. PubMed ID: 26177495
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Efficacy of Sex Hormone-Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS.
Chen F; Liao Y; Chen M; Yin H; Chen G; Huang Q; Chen L; Yang X; Zhang W; Wang P; Yin G
Reprod Sci; 2021 Sep; 28(9):2504-2513. PubMed ID: 33721297
[TBL] [Abstract][Full Text] [Related]
15. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction.
Di Stasi V; Maseroli E; Rastrelli G; Scavello I; Cipriani S; Todisco T; Marchiani S; Sorbi F; Fambrini M; Petraglia F; Maggi M; Vignozzi L
Front Endocrinol (Lausanne); 2021; 12():641446. PubMed ID: 33854482
[TBL] [Abstract][Full Text] [Related]
16. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
Li L; Chen X; He Z; Zhao X; Huang L; Yang D
J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress promotes hyperandrogenism by reducing sex hormone-binding globulin in polycystic ovary syndrome.
Sun Y; Li S; Liu H; Bai H; Hu K; Zhang R; Liu Q; Fan P
Fertil Steril; 2021 Dec; 116(6):1641-1650. PubMed ID: 34433519
[TBL] [Abstract][Full Text] [Related]
18. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome.
Glueck CJ; Morrison JA; Wang P
J Pediatr Endocrinol Metab; 2008 Oct; 21(10):973-84. PubMed ID: 19209619
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
